Tm Bioscience licenses patents for CF (cystic fibrosis) gene test:
This article was originally published in Clinica
Tm Bioscience has acquired a non-exclusive licence for cystic fibrosis (CF) gene mutation patents for use in its Tag-It mutation detection kit. The Tag-It CF test, the firm's flagship product, is currently being assessed by potential customers and is expected to reach the market in the third quarter of 2003, says the Toronto, Ontario company. The CF patents were licensed from The Hospital for Sick Children, also in Toronto, Ontario, and the University of Michigan, in Ann Arbor, Michigan. Other tests in the firm's pipeline include those for genetic mutations related to haematology, toxicology and other debilitating genetic disorders.